Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-16T19:07:53.894Z Has data issue: false hasContentIssue false

Quantifying the diagnostic pathway for patients with cognitive impairment: real-world data from Australia

Published online by Cambridge University Press:  25 November 2019

Christopher M. Black*
Affiliation:
Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA
Michael Woodward
Affiliation:
Aged Care Services and Head, Aged Care Research, Memory and Wound Clinics, Austin Health, Heidelberg, Victoria, Australia
Baishali M. Ambegaonkar
Affiliation:
Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA
Alana Philips
Affiliation:
MSD, Sydney, NSW, Australia
James Pike
Affiliation:
Adelphi Real World, Macclesfield, UK
Eddie Jones
Affiliation:
Adelphi Real World, Macclesfield, UK
Joseph Husbands
Affiliation:
Adelphi Real World, Macclesfield, UK
Rezaul K. Khandker
Affiliation:
Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA
*
Correspondence should be addressed to: Christopher M. Black, Outcomes Research, Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA. Phone: +732 594-3037. Email: christopher.black2@merck.com.
Get access

Abstract

Objectives:

Rapid diagnosis of dementia is essential to ensure optimum patient care. This study used real-world data to quantify the dementia diagnostic pathway in Australia.

Design:

A real-world, cross-sectional survey of physicians and patients.

Setting:

Clinical practice.

Participants:

Primary care or specialist physicians managing patients with cognitive impairment (CI).

Measurements:

Descriptive analyses focused on key events in the diagnostic pathway. Regression modeling compared the duration between first consultation and formal diagnosis with various factors.

Results:

Data for 600 patients were provided by 60 physicians. Mean time from initial symptoms to first consultation was 6.1 ± 4.4 months; 20% of patients had moderate or severe CI at first consultation. Mean time from first consultation to formal diagnosis was 4.0 ± 7.4 months (1.2 ± 3.6 months if not referred to a secondary physician, and 5.3 ± 8.3 months if referred). Time from first consultation to diagnosis was significantly associated with CI severity at first consultation; time was shorter with more severe CI. There was no association of disease severity and referral to a secondary physician; 69.5% of patients were referred, the majority (57.1%) to a geriatrician. The highest proportion of patients were diagnosed by geriatricians (47.4%). Some form of test or scale was used to aid diagnosis in 98.8% of patients.

Conclusions:

A substantial number of Australians experience cognitive decline and behavioral changes some time before consulting a physician or being diagnosed with dementia. Increasing public awareness of the importance of early diagnosis is essential to improve the proportion of patients receiving comprehensive support prior to disease progression.

Information

Type
Original Research Article
Copyright
© International Psychogeriatric Association 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Supplementary material: File

Black et al. supplementary material

Black et al. supplementary material

Download Black et al. supplementary material(File)
File 68.9 KB